Abstract: The present disclosure provides a natural, self-dispersible, anti-microbial pigeon repellent composition. Specifically, the present disclosure provides an anti-microbial pigeon repellent composition that includes essential oils, terpenes, preservatives, binder and emulsifier. Said composition exhibits excellent pigeon repellent activity over a number of surfaces, while being devoid of any harmful chemicals.
[0001] The present invention relates to a pigeon repellent composition. More particularly, the present disclosure provides a natural anti-microbial pigeon repellent composition that exhibits excellent activity over a number of surfaces, while being devoid of any harmful chemicals.
BACKGROUND OF THE INVENTION
[0002] The background description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.
[0003] Mainly regarded as a civic nuisance due to their droppings, pigeons have long been criticized for defacing the properties and monuments which lowers the aesthetic aspects of the building along with increasing the cost of maintenance manifolds. In addition, their dried droppings are the source of spread of many deadly bacterial and fungal diseases and infections, which has a direct impact on human welfare.
[0004] Various devices have been used in the past to prevent pigeons from resting on the buildings and other areas where they are not wanted. Usually, the birds adapt quickly to the presence of such devices and render them useless for their intended function.
[0005] Also, various compositions have been prepared and used to prevent pigeons from resting on the buildings and other locations. Unfortunately, majority of such compositions themselves render the buildings and other locations discolored resulting in economic loss.
[0006] The present invention satisfies the requirements and overcomes the deficiencies generally found in the conventional pigeon repellent compositions.
OBJECTS OF THE INVENTION
[0007] An object of the present disclosure is to provide a natural, self-dispersible pigeon repellent composition.
[0008] Another object of the present disclosure is to provide a pigeon repellent composition that exhibits anti-microbial properties.
[0009] An object of the present disclosure is to provide an anti-microbial pigeon repellent composition that exhibits excellent activity over a number of surfaces.
[0010] Another object of the present disclosure is to provide an anti-microbial pigeon repellent composition that is devoid of any harmful chemicals.
[0011] Still another object of the present disclosure is to provide an anti-microbial pigeon repellent composition that is environment friendly.
[0012] The other objects and preferred embodiments and advantages of the present invention will become more apparent from the following description of the present invention when read in conjunction with the accompanying examples and figures, which are not intended to limit scope of the present invention in any manner.
SUMMARY OF THE INVENTION
[0013] This summary is provided to introduce a selection of concepts in a simplified form that are further described below in Detailed Description section. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
[0014] The present disclosure relates to a natural pigeon repellent composition. Specifically, the present disclosure relates to a pigeon repellent composition that exhibits anti-microbial activity.
[0015] In one aspect, the present disclosure relates to an anti-microbial pigeon repellent composition that exhibits excellent activity over a number of surfaces.
[0016] In one aspect, the present disclosure relates to an anti-microbial pigeon repellent composition that exhibits a surprisingly good anti-microbial activity against widely known diseases caused by bacteria and fungi found in the excretion of pigeons.
[0017] In one aspect, the present disclosure relates to an anti-microbial pigeon repellent composition which compared to commercially available products, is found to be more effective in reducing the degree of reappearance of pigeons, while offering an environment friendly solution.
[0018] In another aspect, the present disclosure provides an anti-microbial pigeon repellent composition including active ingredients, emulsifier, preservative and binder.
[0019] In another aspect, the present disclosure provides an anti-microbial pigeon repellent composition wherein the active ingredients comprise one or more essential oils, one or more terpenes and combinations thereof.
[0020] In yet another aspect, the present disclosure provides an anti-microbial pigeon repellent composition wherein the active ingredients used in the composition exhibit pigeon repellent as well as anti-microbial properties, while being non-toxic to pigeons.
[0021] Other aspects of the invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learnt by the practice of the invention.
DETAILED DESCRIPTION OF THE INVENTION
[0022] The following is a detailed description of embodiments of the disclosure. The embodiments are in such detail as to clearly communicate the disclosure. However, the amount of detail offered is not intended to limit the anticipated variations of embodiments; on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure as defined by the appended claims.
[0023] Unless the context requires otherwise, throughout the specification and claims which follow, the word “comprise” and variations thereof, such as, “comprises” and “comprising” are to be construed in an open, inclusive sense that is as “including, but not limited to.”
[0024] Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
[0025] As used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. It should also be noted that the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
[0026] In some embodiments, the numbers expressing quantities of ingredients, properties such as concentration, reaction conditions, and so forth, used to describe and claim certain embodiments of the invention are to be understood as being modified in some instances by the term “about.” Accordingly, in some embodiments, the numerical parameters set forth in the written description are approximations that can vary depending upon the desired properties sought to be obtained by a particular embodiment. In some embodiments, the numerical parameters should be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of some embodiments of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as practicable.
[0027] The recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g. “such as”) provided with respect to certain embodiments herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.
[0028] The headings and abstract of the invention provided herein are for convenience only and do not interpret the scope or meaning of the embodiments.
[0029] The following discussion provides many example embodiments of the inventive subject matter. Although each embodiment represents a single combination of inventive elements, the inventive subject matter is considered to include all possible combinations of the disclosed elements. Thus if one embodiment comprises elements A, B, and C, and a second embodiment comprises elements B and D, then the inventive subject matter is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly disclosed.
[0030] The present invention relates to a natural pigeon repellent composition. Specifically, the present invention relates to a self-dispersible pigeon repellent composition.
[0031] In an embodiment of the present invention, the pigeon repellent composition exhibits anti-microbial activity.
[0032] In an embodiment of the present invention, the anti-microbial pigeon repellent composition exhibits excellent activity over a number of surfaces, while being devoid of any harmful chemicals.
[0033] In one embodiment, the present disclosure provides an anti-microbial pigeon repellent composition including active ingredients, emulsifier, preservative and binder.
[0034] In another embodiment, the present disclosure provides an anti-microbial pigeon repellent composition wherein the active ingredients comprise one or more essential oils, one or more terpenes and mixtures thereof.
[0035] In an embodiment of the present invention, the essential oil can be selected from the group comprising of lemongrass oil, eucalyptus oil, mixtures thereof and the like. In a preferred embodiment, the essential oil is a mixture of lemongrass oil and eucalyptus oil.
[0036] In an embodiment of the present invention, essential oil can be present in an amount ranging from about 10% to about 50%, preferably about 15% to about 45% by weight of the composition.
[0037] In an embodiment of the present invention, terpenes can be selected from the group comprising of alpha terpinene, fernisol, mixtures thereof and the like. In a preferred embodiment, terpene is alpha terpinene.
[0038] In an embodiment of the present invention, terpenes can be present in an amount ranging from about 2% to about 10%, preferably about 3% to about 8% by weight of the composition.
[0039] In an embodiment of the present invention, emulsifier can be selected from the group comprising of lecithin, polysorbate, mixtures thereof and the like. In a preferred embodiment, the emulsifier is polysorbate-80.
[0040] In an embodiment of the present invention, the one or more emulsifiers can be present in an amount ranging from about 5% to about 35%, preferably about 20% to about 30% by weight of the composition.
[0041] In an embodiment of the present invention, preservative can be selected from the group comprising of potassium sorbate, dehydroacetic acid, sodium benzoate, mixtures thereof and the like. In a preferred embodiment, preservative is potassium sorbate.
[0042] In an embodiment of the present invention, preservative can be present in an amount ranging from about 5% to about 20%, preferably about 8% to about 15% by weight of the composition.
[0043] In an embodiment of the present invention, binder can be selected from the group comprising of water, polyvinylpyrrolidone and the like. In a preferred embodiment, binder is water.
[0044] In an embodiment of the present invention, binder can be present in an amount ranging from about 5% to about 20%, preferably about 8% to about 17% by weight of the composition.
[0045] In an embodiment of the present invention, the anti-microbial pigeon repellent composition comprises:
a) Lemongrass oil;
b) Eucalyptus oil;
c) Alpha terpinene;
d) Polysorbate 80;
e) Potassium sorbate; and
f) Water.
[0046] In another embodiment of the present invention, the anti-microbial pigeon repellent composition comprises:
a) Lemongrass oil 20-30%;
b) Eucalyptus oil 20-30%;
c) Alpha terpinene 3-8%;
d) Polysorbate 80 20-30%;
e) Potassium sorbate 8-15%; and
f) Water 8-17%.
[0047] In a preferred embodiment of the present invention, the anti-microbial pigeon repellent composition comprises:
g) Lemongrass oil 22.22%;
h) Eucalyptus oil 22.22%;
i) Alpha terpinene 5.56%;
j) Polysorbate 80 27.78%;
k) Potassium sorbate 11.11%; and
l) Water 11.11%.
[0048] In an embodiment of the present invention, the anti-microbial pigeon repellent composition is compressed in the form of a “ready to use” liquid concentrate.
[0049] In an embodiment of the present invention, the anti-microbial pigeon repellent composition in the form of a liquid concentrate is dissolved in water to form an aqueous solution that can be used as a spray.
[0050] According to embodiments of the present invention, the liquid concentrate of 30 mL can be further diluted in 470 mL of water to make up to a 500 mL of ready to use Pigeon Repellent.
[0051] In an embodiment of the present invention, the liquid concentrate when dissolved in water has a pH in the range of about 4.5 to about 7.5, preferably about 5 to about 7.
[0052] In an embodiment of the present invention, the anti-microbial pigeon repellent composition can be sprayed at the pigeon roosting sites.
[0053] In an embodiment of the present invention, the anti-microbial pigeon repellent composition is applied daily for 15 consecutive days, then thrice a week, then twice a week and then once a week for a total of 5 weeks.
[0054] In an embodiment of the present invention, after the application of the anti-microbial pigeon repellent composition the pigeons stop returning after 7 to 10 days.
[0055] In an embodiment of the present invention, the pigeon roosting site becomes pigeon free after 2 to 4 months.
[0056] The composition of the present invention is superior as compared to commercially available pigeon repellent called Flutter Bio Bird repellent, wherein the active ingredient is Geraniol. The pigeons reappeared in 3rd day and the droppings were not significantly reduced even after 12th day when Flutter bio bird repellent was used. The composition of the present invention is much superior as its usage leads to efficient pigeon repellency and significant reduction in droppings. The results of Pigeon repelling efficiency of the composition of the present invention are described in detail in Example 3.
[0057] In an embodiment of the present invention, the anti-microbial pigeon repellent composition exhibits a surprisingly good anti-microbial activity against widely known diseases caused by bacteria and fungi found in the excretion of pigeons.
[0058] In an embodiment of the present invention, the anti-microbial pigeon repellent composition when compared to commercially available products is found to be more effective in reducing the degree of reappearance of pigeons, while offering an environment friendly solution. The detailed results of the anti-bacterial and anti-fungal activity of the Pigeon repellent composition are described in detail in Example 4 and 5.
[0059] In an embodiment of the present invention, the active ingredients used in the composition exhibits pigeon repellent as well as anti-microbial properties, while being non-toxic to pigeons. The toxicity study has been described in detail in Example 6.
[0060] Although few representative examples of essential oils, terpenes, preservatives, binders and emulsifiers are provided herein, a person skilled in the art would appreciate that any other known essential oils, terpenes, preservatives, binders, and emulsifiers can also be used to serve the intended purpose as laid down in embodiments of the present disclosure without departing from the scope of the present disclosure.
[0061] While the foregoing describes various embodiments of the disclosure, other and further embodiments of the disclosure may be devised without departing from the basic scope thereof. The scope of the disclosure is determined by the claims that follow. The disclosure is not limited to the described embodiments, versions or examples, which are included to enable a person having ordinary skill in the art to make and use the disclosure when combined with information and knowledge available to the person having ordinary skill in the art.
[0062] The present invention is further explained in the form of following examples. However, it is to be understood that the following examples are merely illustrative and are not to be taken as limitations upon the scope of the invention.
[0063] All the raw materials are commercially available. Lemongrass oil and Eucalyptus oil were purchased from AG Industries, Noida. Alpha Terpinene was purchased from TCI Chemicals, India. Polysorbate 80 and potassium sorbate were purchased from SRL Chemicals.
[0064] Example 1: Composition of Anti-microbial Pigeon repellent
Ingredient %age by weight of the composition Quantity (in g) in 30mL sachet
Lemongrass oil 22.22% 6.66
Eucalyptus oil 22.22% 6.66
Alpha Terpinene 5.56% 1.66
Polysorbate 80 27.78% 8.33
Potassium sorbate 11.11% 3.33
Water 11.11% 3.33
[0065] Example 2: Preparation of Pigeon repellent Composition
[0066] Potassium sorbate (3.33 g) is dissolved in lukewarm water (3.33 g) to make a solution. Lemongrass oil (6.66 g), eucalyptus oil (6.66 g) and alpha terpinene (1.66 g) are mixed to form the active ingredient mixture. Polysorbate 80 (3.33 g) is added to the active ingredient mixture followed by addition of potassium sorbate mixture resulting in 30 mL of “ready to use” Pigeon repellent composition.
[0067] Example 3: Pigeon repellent activity of the composition
[0068] The study was performed at the Pigeon roosting sites, with an area of around 1000 sq inches at average temperature of 31.4°C, humidity of 64% and pressure of 921millibar. The Pigeon roosting sites were cleaned thoroughly followed by sprayed the site with the Pigeon repellent composition as described in Example 1. The pigeon roosting sites were sprayed with 8-9 mL of Pigeon repellent composition i.e., around 18 to 20 sprays. The site was sprayed regularly for first 15 consecutive days, then thrice a week, then twice a week and then once a week for a total of 5 weeks. The appearance of Pigeons and the Pigeon dropping was observed and compared with the control samples. Table 1 shows a correlation between the number of days and the Pigeon appearance (and pigeon droppings) after spraying Pigeon repellent composition of the present invention.
Day No. Number of sprays Time of observation Number of pigeon droppings on the site
Day 0 11:15 AM 17
Day 0 0 6:15 PM 18
Day 1 11:15 AM 18
Day 1 20 6:15 PM 16
Day 2 11:15 AM 10
Day 2 24 6:15 PM 9
Day 3 11:15 AM 8
Day 3 20 6:15 PM 7
Day 4 11:15 AM 4
Day 4 18 6:15 PM 5
Day 5 11:15 AM 4
Day 5 22 6:15 PM 3
Day 6 11:15 AM 3
Day 6 20 6:15 PM 2
Day 7 11:15 AM 1
Day 7 20 6:15 PM 2
Day 8 11:15 AM 1
Day 8 21 6:15 PM 0
Day 9 11:15 AM 0
Day 9 22 6:15 PM 1
Day 10 11:15 AM 0
Day 10 20 6:15 PM 0
Day 11 11:15 AM 0
Day 11 24 6:15 PM 0
Day 12 11:15 AM 0
Day 12 24 6:15 PM 0
Day 13 11:15 AM 0
Day 13 20 6:15 PM 0
Day 14 11:15 AM 0
Day 14 18 6:15 PM 0
[0069] The Pigeon repellent composition is effective in repelling pigeons within 10 days when sprayed daily. The pigeon droppings were observed daily before and after spraying and it has been observed that the number of dropping decreased day by day and no droppings were observed from day 9th onwards indicating that pigeons stopped coming to the site that was sprayed with the Pigeon repellent composition.
[0070] Example 4: Anti-bacterial activity of the Pigeon repellent composition
[0071] The method used to determine the anti-bacterial activity of the Pigeon repellent is based on the inoculation of a standardized liquid culture of the test strain in a dilution series of the tested antibacterial for which the MIC is determined. The first concentration in the dilution series at which no visual growth can be determined is then considered as the MIC. Graph was plotted with respect to Log concentration of the test product and Probit of mortality for calculation of LC50 against bacterial strains Escherichia coli (ATCC 8739) and Salmonella typhimurium (ATCC 23564).
[0072] Procedure: The working culture of bacteria (E.coli and S. typhimurium) was prepared. Stock solution of the test organism was prepared as to obtain a count of at least 5 x 105 cfu per ml by using densitometer. The concentration of Pigeon Repellent composition taken was 100 mg/ml to 10 mg/ml, prepared in Soybean Casein Digest Medium (SCDM). After preparation of all the tubes, a 100µl of the adjusted culture (approx.105cfu/ml) was added in to each tube and all the tubes were incubated for 24 hours. After incubation, all the tubes were visually observed for growth of microorganisms. The effectiveness of the antibacterial activity of Pigeon Repellent composition was recorded in terms of MIC. The concentration at which the growth of test organisms is inhibited was considered as the MIC of composition. Graph was plotted with respect to Log concentration of the test product and Probit of mortality.
[0073] The antibacterial activity of Pigeon Repellent composition was calculated in terms of LC50 against Escherichia coli and Salmonella typhimurium and resulted in LC50 of 47.86 mg/ml against Escherichia coli and 50.11 mg/ml against Salmonella typhimurium.
[0074] Example 5: Anti-Fungal activity of the Pigeon repellent composition
[0075] Fungal Strain Cryptococcus neoformans (NCIM 3378), Candida albicans (ATCC 10231) and Saccharomyces cerevisiae (ATCC 9763) were used to evaluate the anti-fungal activity of the Pigeon Repellent composition.
[0076] Procedure: The working culture of test organism (Cryptococcus neoformans, Candida albicans and Saccharomyces cerevisiae was prepared. Stock solution of the test organism was prepared as to obtain a count of at least 0.5-2.5 x 103 cfu per ml by using densitometer. The concentration of Pigeon Repellent composition taken was 100mg/ml to 10mg/ml. The concentration of sample was prepared in SCDM. After preparation of all the tubes, a 100µl of the adjusted culture (approx.103 cfu/ml) was added in to each tube and all the tubes were incubated for 72 hours. After incubation, all the tubes were visually observe for growth of microorganisms. The concentration at which the growth of test organisms is inhibited was considered as the MIC of product. The effectiveness of the antifungal activity of Pigeon Repellent composition was recorded in terms of MIC. Graph was plotted with respect to Log concentration of the test product and Probit of mortality.
[0077] The antifungal activity of Pigeon Repellent Composition resulted in LC50 against Cryptococcus neoformans as 50.11mg/ml, LC50 against Candida albicans as 50.11mg/ml and LC50 against Saccharomyces cerevisiae was 47.86mg/ml.
[0078] Example 6: In-vitro cytotoxicity study of the Pigeon repellent composition
[0079] To assess the cytotoxic potential of the Pigeon Repellent Composition, ‘In-vitro cytotoxicity study’ on L-929 mouse fibroblast cells was carried out. The study was conducted as per International Organization for Standardization ISO 10993-5:2009, Biological evaluation of medical devices-Part 5: Tests for in vitro.
[0080] The in-vitro cytotoxicity study specifies the incubation of cultured cells with the Pigeon Repellent composition. A preliminary study was conducted with different range of concentrations of the composition. On the outcome of preliminary study, doses for main cytotoxicity assay were selected. Negative control and positive control were prepared by using culture medium with 10% serum. Serum-supplemented DMEM cell culture media was used. Negative control used was culture Medium containing 10% FBS whereas Positive control was Liquefied Phenol at 1.6 mg/ml in culture media. The composition in four different concentrations (1mg/ml, 2mg/ml, 4mg/ml and 8mg/ml) was added onto three separate nearly 80% confluent monolayer of L-929 mouse fibroblast cells. Similarly the negative control and positive control was placed onto separate nearly 80% confluent monolayer in triplicates. All the monolayers were incubated at 37±1°C in the presence of 5±1% carbon dioxide for 24 hours. At 24 hour the monolayer of the composition, negative control and positive control were examined microscopically. 50µl of MTT solution were transferred into multi well plate. All the wells were incubated at 37±1°C in an incubator in the presence of 5 ±1 % Carbon dioxide for 2hrs.Then the MTT solution was decanted and 100µl of isopropanol (acidified) were added in each well and subsequently absorbance recorded at 570nm.
[0081] Under the condition of this study, the viability % of L929 cells treated with Pigeon Repellent composition at dose concentration 2mg/ml, came out as > 70 % when compared to its control counterpart. Therefore, the dose concentration 2mg/ml was found to be Non- Cytotoxic.
[0082] The confluency of the monolayer was recorded as (+) if present and (-) if absent. Each culture well was evaluated for Viability percent by MTT Cytotoxicity test. To calculate the reduction of viability compared to control, the following equation was used:
Where
OD570e is the absorbance of the 100% extract of test sample
OD570b is the absorbance of the control
The Lower the Viability %, the higher the cytotoxic potential of the test item. If Viability is reduced <70% of the blank, it has a cytotoxic potential.
[0083] The Pigeon Repellent composition was found to be non-cytotoxic at dose concentration of 2mg/ml when Viability % and cellular Characteristics of cells was compared with Negative control.
[0084] The foregoing examples are merely illustrative and are not to be taken as limitations upon the scope of the invention. Various changes and modifications to the disclosed embodiments will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the scope of the invention.
ADVANTAGES OF THE INVENTION
[0085] The present disclosure provides an anti-microbial pigeon repellent composition.
[0086] The present disclosure provides a pigeon repellent composition that exhibits anti-microbial properties.
[0087] The present disclosure provides a natural and self-dispersible anti-microbial pigeon repellent capsule composition.
[0088] The present disclosure provides an anti-microbial pigeon repellent composition that exhibits excellent activity over a number of surfaces.
[0089] The present disclosure provides an anti-microbial pigeon repellent composition that is devoid of any harmful chemicals.
[0090] The present disclosure provides an environment friendly anti-microbial pigeon repellent composition.
WE CLAIM
1.An anti-microbial pigeon repellent composition comprising active ingredients, emulsifier, preservative and binder, wherein the active ingredients comprise one or more essential oils, one or more terpenes and combinations thereof.
2. The composition as claimed in claim 1, wherein the essential oil is selected from a group comprising of lemongrass oil, eucalyptus oil and mixtures thereof, preferably a mixture of lemongrass oil and eucalyptus oil, present in an amount ranging from 10% to 50%, preferably 15% to 45% by weight of the composition.
3. The composition as claimed in claim 1, wherein terpenes are selected from the group comprising of alpha terpinene, fernisol and mixtures thereof, preferably alpha terpinene, present in an amount ranging from 2% to 10%, preferably 3% to 8% by weight of the composition.
4. The composition as claimed in claim 1, wherein emulsifier is from the group comprising of lecithin, polysorbate and mixtures thereof, preferably polysorbate-80, present in an amount ranging from 5% to 35%, preferably 20% to 30% by weight of the composition.
5. The composition as claimed in claim 1, wherein preservative is selected from the group comprising of potassium sorbate, dehydroacetic acid, sodium benzoate and mixtures thereof, preferably potassium sorbate, present in an amount ranging from 5% to 20%, preferably 8% to 15% by weight of the composition.
6. The composition as claimed in claim 1, wherein binder is water, present in an amount ranging from 5% to 20%, preferably 8% to 17% by weight of the composition.
7. The composition as claimed in claim 1, wherein the anti-microbial pigeon repellent composition comprises:
a) Lemongrass oil;
b) Eucalyptus oil;
c) Alpha terpinene;
d) Polysorbate 80;
e) Potassium sorbate; and
f) Water.
8. The composition as claimed in claim 1, wherein the anti-microbial pigeon repellent composition comprises:
a) Lemongrass oil 20-30%;
b) Eucalyptus oil 20-30%;
c) Alpha terpinene 3-8%;
d) Polysorbate 80 20-30%;
e) Potassium sorbate 8-15%; and
f) Water 8-17%.
9. The composition as claimed in claims 1-8 wherein composition is compressed in the form of a “ready to use” liquid concentrate, which when dissolved in water has a pH in the range of about 4.5 to about 7.5, preferably about 5 to about 7.
10. An anti-microbial pigeon repellent composition comprising:
a) Lemongrass oil 22.22%;
b) Eucalyptus oil 22.22%;
c) Alpha terpinene 5.56%;
d) Polysorbate 80 27.78%;
e) Potassium sorbate 11.11%; and
f) Water 11.11%.
| # | Name | Date |
|---|---|---|
| 1 | 202011005219-STATEMENT OF UNDERTAKING (FORM 3) [06-02-2020(online)].pdf | 2020-02-06 |
| 2 | 202011005219-PROVISIONAL SPECIFICATION [06-02-2020(online)].pdf | 2020-02-06 |
| 3 | 202011005219-FORM FOR STARTUP [06-02-2020(online)].pdf | 2020-02-06 |
| 4 | 202011005219-FORM FOR SMALL ENTITY(FORM-28) [06-02-2020(online)].pdf | 2020-02-06 |
| 5 | 202011005219-FORM 1 [06-02-2020(online)].pdf | 2020-02-06 |
| 6 | 202011005219-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [06-02-2020(online)].pdf | 2020-02-06 |
| 7 | 202011005219-EVIDENCE FOR REGISTRATION UNDER SSI [06-02-2020(online)].pdf | 2020-02-06 |
| 8 | 202011005219-DECLARATION OF INVENTORSHIP (FORM 5) [06-02-2020(online)].pdf | 2020-02-06 |
| 9 | 202011005219-Proof of Right [26-02-2020(online)].pdf | 2020-02-26 |
| 10 | 202011005219-FORM-26 [26-02-2020(online)].pdf | 2020-02-26 |
| 11 | 202011005219-ENDORSEMENT BY INVENTORS [02-02-2021(online)].pdf | 2021-02-02 |
| 12 | 202011005219-CORRESPONDENCE-OTHERS [02-02-2021(online)].pdf | 2021-02-02 |
| 13 | 202011005219-COMPLETE SPECIFICATION [02-02-2021(online)].pdf | 2021-02-02 |
| 14 | 202011005219-RELEVANT DOCUMENTS [25-04-2023(online)].pdf | 2023-04-25 |
| 15 | 202011005219-POA [25-04-2023(online)].pdf | 2023-04-25 |
| 16 | 202011005219-FORM 13 [25-04-2023(online)].pdf | 2023-04-25 |